Suppression of dolichol synthesis with isoprenoids and statins may potentiate the cancer-retardant efficacy of IGF-I down-regulation
To access this article, please choose from the options below
PII: S0306-9877(00)91073-9
doi:10.1054/mehy.2000.1073
© 2001 Harcourt Publishers Ltd. All rights reserved.
